Increase/Decrease in Cash: The total change in cash for the company over the given period.
Cardiff Oncology, Inc. (CRDF) had Increase/Decrease in Cash of $-40.69M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.12M |
|
$-13.95M |
|
-- |
|
$0.12M |
|
$14.90M |
|
$-14.78M |
|
$0.83M |
|
$-13.94M |
|
$-13.94M |
|
$-13.94M |
|
$-13.94M |
|
$-13.94M |
|
$-13.94M |
|
$-14.78M |
|
$-14.98M |
|
66.53M |
|
66.53M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$73.70M |
|
$0.74M |
|
$2.04M |
|
$75.74M |
|
$16.67M |
|
-- |
|
$0.46M |
|
$17.13M |
|
$58.61M |
|
$58.61M |
|
$58.61M |
|
66.53M |
|
| Cash Flow Statement Financials | |
$-21.12M |
|
$-19.57M |
|
$0.00M |
|
$51.47M |
|
$10.78M |
|
|
Increase/Decrease in Cash |
$-40.69M |
$3.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-12212.40% |
|
-12212.40% |
|
-- |
|
-11523.14% |
|
-11528.10% |
|
$-21.15M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.23 |
|
391.24 |
|
-23.79% |
|
-23.79% |
|
-18.41% |
|
-23.79% |
|
$0.88 |
|
$-0.32 |
|
$-0.32 |
|